These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
57 related items for PubMed ID: 8261446
1. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Kornblau SM, Chen N, del Giglio A, O'Brien S, Deisseroth AB. Cancer Res; 1994 Jan 01; 54(1):242-6. PubMed ID: 8261446 [Abstract] [Full Text] [Related]
2. Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study. Kornblau SM, Andreeff M, Hu SX, Xu HJ, Patel S, Theriault A, Koller C, Kantarjian H, Estey E, Deisseroth AB, Benedict WF. Clin Cancer Res; 1998 Aug 01; 4(8):1955-63. PubMed ID: 9717825 [Abstract] [Full Text] [Related]
3. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia. Liso V, Capalbo S, Lapietra A, Pavone V, Guarini A, Specchia G. Haematologica; 1999 Mar 01; 84(3):212-7. PubMed ID: 10189384 [Abstract] [Full Text] [Related]
5. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells. De Fanis U, Romano C, Dalla Mora L, Sellitto A, Guastafierro S, Tirelli A, Bresciano E, Giunta R, Lucivero G. Oncol Rep; 2003 Mar 01; 10(3):653-8. PubMed ID: 12684639 [Abstract] [Full Text] [Related]
7. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination. Rutella S, Rumi C, Puggioni P, Barberi T, Di Mario A, Larocca LM, Leone G. Haematologica; 1999 May 01; 84(5):419-24. PubMed ID: 10329920 [Abstract] [Full Text] [Related]
8. Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Kornblau SM, Xu HJ, del Giglio A, Hu SX, Zhang W, Calvert L, Beran M, Estey E, Andreeff M, Trujillo J. Cancer Res; 1992 Sep 01; 52(17):4587-90. PubMed ID: 1511426 [Abstract] [Full Text] [Related]
13. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors. Chiotoglou I, Smilevska T, Samara M, Likousi S, Belessi C, Athanasiadou I, Stavroyianni N, Samara S, Laoutaris N, Vamvakopoulos N, Anagnostopoulos A, Fassas A, Stamatopoulos K, Kollia P. Blood Cells Mol Dis; 2008 Sep 01; 41(2):203-9. PubMed ID: 18621559 [Abstract] [Full Text] [Related]
15. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis. Nagy B, Ferrer A, Larramendy ML, Galimberti S, Aalto Y, Casas S, Vilpo J, Ruutu T, Vettenranta K, Franssila K, Knuutila S. Haematologica; 2003 Jun 01; 88(6):654-8. PubMed ID: 12801841 [Abstract] [Full Text] [Related]
16. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A. Am J Pathol; 1996 May 01; 148(5):1591-600. PubMed ID: 8623927 [Abstract] [Full Text] [Related]